CSL Ltd. is cutting its full-year profit outlook after flagging substantial additional impairment charges. The company says it expects about US$5 billion (about A$6.9 billion) in new impairments, following a review led by its interim chief executive. CSL also indicates that the turnaround will take longer than previously expected, attributing the extended timeframe to the findings of that review. The impairment outlook and revised earnings guidance reflect updated assessments of the value of certain assets and/or related risks, with CSL communicating that these changes will affect near-term results. While the company provides a broad sense of the scale of the impairment figure and the timing implications for its recovery plan, the reported accounts do not specify detailed drivers for each impairment category. Overall, CSL’s updated guidance signals a more challenging operating and financial outlook than earlier projections, with management pointing to the review as the basis for both the increased impairments and the slower-than-expected turnaround.